Recent Blog Posts

View Post: Treatment of cystic fibrosis : encouraging new results for ...
23 Jul 2009 by insciences  
In new work to be published on 1 August 2009 in the American Journal of Respiratory Cell and Molecular Biology, the researchers show that daily, long-term treatment of human cystic fibrosis cells with low doses of miglustat corrects the ...
View Blog: Articles - http://insciences.org/articles.php

---

View Post: actelion informs us physicians over possible employment of zavesca ...
8 Sep 2009
actelion informs us physicians about possible employment of zavesca® (miglustat, oral cap) for the compensation of the delivery bottleneck during the intravenous enzyme spare replacement (imiglucerase) for patients with typ-1 gaucher ...
View Blog: kissjet - http://kissjet.com/

---

View Post: Miglustat (Zavesca®) launched in UK for treatment of Niemann-Pick ...
20 Jul 2009
Actelion Ltd has announced the launch of miglustat (Zavesca®) in the UK as the first and only licensed treatment of Niemann-Pick type C (NP-C) disease, a rare, genetic disease whose key feature is significant, and potentially fatal ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/

---

View Post: treatment of cystic fibrosis: encouraging new results for miglustat
22 Jul 2009 by Biunce  
miglustat is a drug currently under phase 2 clinical trials on patients suffering from cystic fibrosis. its potential for treating the disease was discovered in 2006 and researchers can now show that daily, long-term treatment of human ...
View Blog: Health News - http://www.doiget.com/in/

---

View Post: treatment of cystic fibrosis: encouraging new results for ...
21 Jul 2009 by cystic fibrosis - Google News  
treatment of cystic fibrosis: encouraging new results for miglustat science daily (press release) (press release) sciencedaily (july 21, 2009) — miglustat is a drug currently under phase 2 clinical trials on patients suffering from ...
View Blog: Paige - http://47.org/47org/

---

View Post: zavesca(r) (miglustat) first treatment available in uk and ireland ...
21 Jul 2009
actelion ltd (six: atln) announced the launch of zavesca (miglustat) in the uk and republic of ireland; the first and only licensed treatment available for people with niemann-pick type c (np-c) disease [1]. np-c is a rare, ...
View Blog: Latest Child Health News Articles at Baby... - http://www.mummums.com/news

---